Enanta Pharmaceuticals, Inc. (9EP.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:13AM CEST. Market open.
| Previous close | 12.70 |
| Open | 12.60 |
| Bid | 12.60 x 15600 |
| Ask | 12.70 x 15300 |
| Day's range | 12.60 - 12.60 |
| 52-week range | 7.50 - 33.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 266.839M |
| Beta (5Y monthly) | 0.49 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
The analysts might have been a bit too bullish on Enanta Pharmaceuticals, Inc. ( NASDAQ:ENTA ), given that the company...
- Insider Monkey
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript February 7, 2024 Enanta Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to Enanta Pharmaceuticals’ Fiscal First Quarter Financial Results Conference Call. At this time, […]
- Thomson Reuters StreetEvents
Q1 2024 Enanta Pharmaceuticals Inc Earnings Call
Q1 2024 Enanta Pharmaceuticals Inc Earnings Call
© 2024 Yahoo. All rights reserved.